Promethera Biosciences
PrivateLast Round
Corporate Funding
Jun 30, 2021
Total Funding Raised
$134.6M
Company Overview
Promethera Biosciences is a biotechnology company that develops innovative cell-based therapies for the treatment of severe liver diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Promethera Biosciences Comparables
Compare Promethera Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GoLiver Therapeutics | 85% | |
| Morphocell Technologies | 82% | |
| HepaTx Corporation | 78% |
Promethera Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jun 30, 2021 | ||||
| Series D | May 7, 2019 | ||||
| Series C Extension | Oct 28, 2016 | ||||
| Series C | Nov 25, 2014 | ||||
| Series B | Mar 28, 2012 | ||||
Series A | Nov 9, 2009 |
Promethera Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series C |
| Sopartec | Series A, Corporate Funding, Series B |
| SMS Investments | Series C, Series C Extension |
| LRM | Series A |
| Korea Investment Partners | Series D |
| Mitsui Global Investment | Series D, Series C, Series B |
| Shinsei Capital Partners | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2021
$24M raised from Fund+, Nivelinvest, Sambrinvest, and Sopartec.
- May 7, 2019
$53M round led by Innovation Fund and Itochu Corporation.
Promethera Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Promethera Biosciences's valuation, stock price, and market status.
Is Promethera Biosciences a public or private company?
Promethera Biosciences is a private company.
What is the current stock price of Promethera Biosciences?
Promethera Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Promethera Biosciences worth (valuation)?
Valuation information for Promethera Biosciences is not publicly available.
Can I buy Promethera Biosciences stock?
Promethera Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Promethera Biosciences's last funding round?
Funding round information for Promethera Biosciences is not publicly available.
Who are the main investors in Promethera Biosciences?
Investor information for Promethera Biosciences is not publicly disclosed.
Will Promethera Biosciences IPO soon?
No public IPO plans have been announced for Promethera Biosciences.
How can I track Promethera Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Promethera Biosciences's secondary market activity and sign up for updates.